🇺🇸 Optifree Replenish in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 9

Most-reported reactions

1. Keratitis Fungal — 2 reports (22.22%)
2. Blindness Unilateral — 1 report (11.11%)
3. Corneal Scar — 1 report (11.11%)
4. Corneal Transplant — 1 report (11.11%)
5. Fusarium Infection — 1 report (11.11%)
6. Herpes Ophthalmic — 1 report (11.11%)
7. Intraocular Pressure Increased — 1 report (11.11%)
8. Transmission Of An Infectious Agent Via A Medicinal Product — 1 report (11.11%)

Source database →

Frequently asked questions

Is Optifree Replenish approved in United States?

Optifree Replenish does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Optifree Replenish in United States?

University of Waterloo is the originator. The local marketing authorisation holder may differ — check the official source linked above.